| |
|
HCV | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 6. | Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis |
| |
Cancer Med. 2023 Apr 20. doi: 10.1002/cam4.5711. Online ahead of print.
Chiara Rocha 1, Erin H Doyle 2, Chip A Bowman 3, M-Isabel Fiel 4, Ashley E Stueck 5, Nicolas Goossens 6, Kian Bichoupan 7, James F Crismale 7, Jasnit Makkar 8, Sara Lewis 9, Ponni V Perumalswami 10, Thomas D Schiano 7, Yujin Hoshida 11, Myron Schwartz 12, Andrea D Branch 7, Neal Patel 13
|
|
| |
| 7. | Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis |
| |
Cancer Med. 2023 Apr 20. doi: 10.1002/cam4.5711. Online ahead of print.
Chiara Rocha 1, Erin H Doyle 2, Chip A Bowman 3, M-Isabel Fiel 4, Ashley E Stueck 5, Nicolas Goossens 6, Kian Bichoupan 7, James F Crismale 7, Jasnit Makkar 8, Sara Lewis 9, Ponni V Perumalswami 10, Thomas D Schiano 7, Yujin Hoshida 11, Myron Schwartz 12, Andrea D Branch 7, Neal Patel 13
|
|
| |
|
|
| |
|
|
| |
| 10. | Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study |
| |
Life (Basel). 2023 Apr 17;13(4):1033. doi: 10.3390/life13041033.
Samir Kamat 1, Sankeerth Kondapalli 2, Shumayl Syed 1, Gabrielle Price 1, George Danias 1, Ksenia Gorbenko 1 3, Joel Cantor 4, Pamela Valera 5 6, Aakash K Shah 7, Matthew J Akiyama 8
|
|
| |
| 11. | Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis |
| |
Hepatol Commun. 2023 Mar 17;7(4):e0082.doi: 10.1097/HC9.0000000000000082. eCollection 2023 Apr 1.
Lakshmi Manoharan 1, Ned H Latham 1, Stephanie C Munari 1, Michael W Traeger 1 2, Vinay Menon 1, Niklas Luhmann 3, Rachel Baggaley 3, Virginia Macdonald 3, Annette Verster 3, Nandi Siegfried 4, Gail V Matthews 5, Mark Stoové 1 2, Margaret E Hellard 1 2 6 7, Joseph S Doyle 1 2 6
|
|
| |
|
|
| |
|
|
| |
| 14. | Elimination of hepatitis C virus in a prison: An 18-year experience |
| |
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr 26;S2529-993X(23)00128-4.doi: 10.1016/j.eimce.2023.04.015. Online ahead of print.
Maite Nogales-Garcia 1, Naiara Parraza Diez 2, Andoni Vargas Axpe 3, Rafael Velasco Garcia 3, Ane Larrabeiti-Etxebarria 4, Ignacio Roy Lopez-Cano 3, Inmaculada Atrio Alvarez 3, Asier Lopez de Arcaute Trincado 3, Eva María Fernandez Lopez de Vicuña 1, Ester Saez de Adana Arroniz 4, Carlos Martínez Martínez 4, Joseba Portu Zapirain 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 20. | Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK |
| |
Liver Int. 2023 Apr;43(4):917-927. doi: 10.1111/liv.15528. Epub 2023 Feb 20.
Victoria Hamill 1 2, Will Gelson 3, Douglas MacDonald 4, Paul Richardson 5, Stephen D Ryder 6, Mark Aldersley 7, Stuart McPherson 8, Sumita Verma 9 10, Rohini Sharma 11, Sharon Hutchinson 1 2, Jennifer Benselin 6, Eleanor Barnes 12, Indra Neil Guha 6 13, William L Irving 6, Hamish Innes 1 2 14
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 24. | Spontaneous Clearance of Vertically Acquired Hepatitis C Infection: Implications for Testing and Treatment |
| |
Clin Infect Dis. 2023 Mar 4;76(5):913-991. doi: 10.1093/cid/ciac255.
A E Ades 1, Fabiana Gordon 1, Karen Scott 2, Intira Jeannie Collins 2, Claire Thorne 3, Lucy Pembrey 4, Elizabeth Chappell 2, Eugènia Mariné-Barjoan 5, Karina Butler 6, Giuseppe Indolfi 7, Diana M Gibb 2, Ali Judd 2
|
|
| |
| 25. | Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy |
| |
J Virus Erad. 2023 Mar 2;9(1):100319. doi: 10.1016/j.jve.2023.100319. eCollection 2023 Mar.
M Schwarz 1 2 3, C Schwarz 1 2 3, A Schütz 4, C Schwanke 4, E Krabb 4, R Schubert 4, S-T Liebich 4, D Bauer 1 2 3, L Burghart 1 2 3, L Brinkmann 1 2 3, E Gutic 1, T Reiberger 2 3, H Haltmayer 4, M Gschwantler 1 5
|
|
| |
| 26. | Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study |
| |
J Viral Hepat. 2023 May;30(5):397-405. doi: 10.1111/jvh.13807. Epub 2023 Feb 13.
Norah A Terrault 1 2, Jennifer Slepin 1, Rachel Kanner 1, Keri Gailloux 1, Lisa Catalli 1, Jeff McKinney 1, Stephanie Straley 1, Portia Morris 3, Rebecca Hluhanich 4, Alicia Gonzalez-Flores 5, Jennifer Dodge 2 6, Souvik Sarkar 7 8
|
|
| |
|
|
| |
|
|
| |
| 29. | Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track? |
| |
Open Forum Infect Dis. 2023 Mar 22;10(4):ofad153. doi: 10.1093/ofid/ofad153.eCollection 2023 Apr.
Jaskaran S Cheema 1, William C Mathews 1, Adriane Wynn 1, Laura B Bamford 1, Francesca J Torriani 1, Lucas A Hill 1, Amutha V Rajagopal 1, Jeffrey Yin 1, Sonia Jain 2, Richard S Garfein 1, Edward R Cachay 1, Natasha K Martin 1 3
|
|
| |
|
|
| |
| 31. | Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission |
| |
Clin Infect Dis. 2023 Mar 4;76(5):905-912. doi: 10.1093/cid/ciac270.
Anthony E Ades 1, Fabiana Gordon 1, Karen Scott 2, Intira J Collins 2, Thorne Claire 3, Lucy Pembrey 4, Elizabeth Chappell 2, Eugènia Mariné-Barjoan 5, Karina Butler 6, Giuseppe Indolfi 7, Diana M Gibb 2, Ali Judd 2
|
|
| |
| 32. | Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct-acting antivirals |
| |
J Viral Hepat. 2023 Mar 5. doi: 10.1111/jvh.13826. Online ahead of print.
Ranya Selim 1, Stuart C Gordon 1 2, Yueren Zhou 3, Talan Zhang 4, Mei Lu 4, Yihe G Daida 5, Joseph A Boscarino 6, Mark A Schmidt 7, Sheri Trudeau 4, Loralee B Rupp 8, Humberto C Gonzalez 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 41. | Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility |
| |
Med J Aust. 2023 Mar 14. doi: 10.5694/mja2.51885. Online ahead of print.
Michael B MacIsaac 1 2, Bradley Whitton 1, Adrian Hubble 1, Shelley Cogger 3, Matthew Penn 3, Anthony Weeks 3, Kasey Elmore 3, David Pemberton 3, Jenine Anderson 3, Rebecca Howard 1, Una McKeever 1, Timothy Papaluca 1 2, Margaret E Hellard 4 5 6, Mark Stoove 4 5, David Wilson 4, Alisa Pedrana 4 5, Joseph Doyle 4 6, Nico Clark 3 7, Jacinta Holmes 1 2, Alexander J Thompson 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 45. | Global reporting of progress towards elimination of hepatitis B and hepatitis C |
| |
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):332-342. doi: 10.1016/S2468-1253(22)00386-7.Epub 2023 Feb 8.
Fuqiang Cui 1, Sarah Blach 2, Casimir Manzengo Mingiedi 3, Monica Alonso Gonzalez 4, Ahmed Sabry Alaama 5, Antons Mozalevskis 6, Nicole Séguy 6, Bharat Bhushan Rewari 7, Po-Lin Chan 8, Linh-Vi Le 8, Meg Doherty 9, Niklas Luhmann 9, Philippa Easterbrook 9, Mae Dirac 10, Catherine de Martel 11, Shevanthi Nayagam 12, Timothy B Hallett 12, Peter Vickerman 13, Homie Razavi 2, Olufunmiayo Lesi 9, Daniel Low-Beer 14
|
|
| |
|
|
| |
| 47. | Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study) |
| |
Clin Infect Dis. 2023 Feb 8;76(3):e607-e612. doi: 10.1093/cid/ciac680.
Malte B Monin 1 2, Patrick Ingiliz 3, Thomas Lutz 4, Stefan Scholten 5, Christiane Cordes 6, Maria Martínez-Rebollar 7, Christoph D Spinner 8, Mark Nelson 9, Michael Rausch 10, Sanjay Bhagani 11, Lars Peters 12, Thomas Reiberger 13, Stefan Mauss 14, Jürgen K Rockstroh 1 2 15, Christoph Boesecke 1 2 15; PROBE-C study group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 52. | Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C |
| |
J Viral Hepat. 2023 Feb;30(2):129-137. doi: 10.1111/jvh.13774. Epub 2022 Dec 8.
Zak Hyde 1, Raúl Roura 1, Danielle Signer 1, Anuj Patel 1, Jacob Cohen 1, Mustapha Saheed 1, Sherilyn Brinkley 2, Risha Irvin 2, Mark S Sulkowski 2, David L Thomas 2, Richard E Rothman 1 2, Yu-Hsiang Hsieh 1
|
|
| |
| 53. | A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019 |
| |
Euro Surveill. 2023 Feb;28(6):2200184. doi: 10.2807/1560-7917.ES.2023.28.6.2200184.
Anthony Nardone 1, Lina Nerlander 2, Erika Duffell 2, Marta Valenciano 1, Maria Buti 3, Cristina Marcos-Fosch 3, Tatjana Nemeth-Blažic 4, Odette Popovici 5, Adriana Vince 6, Petruta Violeta Filip 7, Tajana Filipec 8, Mirjana Lana Kosanovic Licina 9, Boris Luksic 10, Diana Nonkovic 11, Corina Silvia Pop 7, Fabiana Radu 7, Irina Teodorescu 12, Adriana Violeta Topan 13
|
|
| |
| 54. | Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study |
| |
Int J Drug Policy. 2023 Feb 27;114:103982. doi: 10.1016/j.drugpo.2023.103982.Online ahead of print.
Jason Grebely 1, Rosie Gilliver 2, Tony McNaughton 3, Anna Conway 4, Evan Cunningham 4, Charles Henderson 3, Brett Hadlow 2, Katrina Molloy 2, Anna Doab 2, Shane Tillakeratne 4, Lucy Pepolim 3, Mary Ellen Harrod 3, Gregory J Dore 4, Phillip Read 5
|
|
| |
|
|
| |
| 56. | How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States |
| |
Int J Drug Policy. 2023 Feb;112:103930. doi: 10.1016/j.drugpo.2022.103930. Epub 2023 Jan 13.
Suzan M Walters 1, David Frank 2, Marisa Felsher 3, Jessica Jaiswal 4, Scott Fletcher 5, Alex S Bennett 6, Samuel R Friedman 7, Lawrence J Ouellet 8, Danielle C Ompad 2, Wiley Jenkins 9, Mai T Pho 10
|
|
| |
| 57. | Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis |
| |
J Viral Hepat. 2023 Feb;30(2):160-171. doi: 10.1111/jvh.13780. Epub 2022 Dec 20.
Zoë R Greenwald 1 2, Zachary Bouck 1 2, Elizabeth McLean 2, Kate Mason 3, Bernadette Lettner 3, Jennifer Broad 3, Zoë Dodd 4, Tanner Nassau 5, Ayden I Scheim 2 5 6, Dan Werb 2 7 8
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 61. | Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH) |
| |
JHEP Rep. 2022 Oct 28;5(1):100614. doi: 10.1016/j.jhepr.2022.100614. eCollection 2023 Jan.
Fabienne Marcellin 1, Sylvie Brégigeon-Ronot 2, Clémence Ramier 1, Camelia Protopopescu 1, Camille Gilbert 3, Vincent Di Beo 1, Claudine Duvivier 4 5 6 7, Morgane Bureau-Stoltmann 1, Eric Rosenthal 1 8, Linda Wittkop 3 9, Dominique Salmon-Céron 10 11, Patrizia Carrieri 1, Philippe Sogni 11 12 13, Tangui Barré 1; ANRS CO13 HEPAVIH Study Group; Scientific Committee; Clinical Centers (ward: participating physicians); Data collection; Management, statistical analyses
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 73. | Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts |
| |
BMC Public Health. 2023 Jan 7;23(1):54. doi: 10.1186/s12889-022-14911-1.
Emma Robinson # 1 2, Christopher J Byrne # 3 4 5, James Carberry 1 2, Andrew Radley 2 6, Lewis J Beer 7, Sarah K Inglis 7, Jan Tait 1, Iain Macpherson 2, David Goldberg 8 9, Sharon J Hutchinson 8 9, Matthew Hickman 10, John F Dillon 1 2
|
|
| |
|
|
| |
|
|
| |
| 76. | The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C |
| |
Trials. 2023 Jan 27;24(1):63.doi: 10.1186/s13063-022-07018-w.
Sarah E Rowan 1 2, Jason Haukoos 3 4 5, Kevin F Kamis 2, Emily Hopkins 6 7, Stephanie Gravitz 6 7, Carolynn Lyle 6 7, Alia A Al-Tayyib 2 8, Edward M Gardner 1 2, James W Galbraith 9, Yu-Hsiang Hsieh 10, Michael S Lyons 11, Richard E Rothman 10, Douglas A E White 12, Jake R Morgan 13 14, Benjamin P Linas 14 15, Allison L Sabel 16 17, David L Wyles 1; DETECT Hep C Trials Investigators
|
|
| |
| 77. | Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States |
| |
Drug Alcohol Depend. 2022 Dec 1;241:109673. doi: 10.1016/j.drugalcdep.2022.109673.Epub 2022 Oct 22.
Po-Hung Chen 1, Karine Yenokyan 2, Anthony T Fojo 3, Heidi E Hutton 4, Catherine R Lesko 2, Mary E McCaul 4, Cui Yang 5, Edward R Cachay 6, Heidi M Crane 7, Jeffrey M Jacobson 8, H Nina Kim 7, Mari M Kitahata 7, Kenneth H Mayer 9, Richard D Moore 10, Sonia Napravnik 11, Michael Saag 12, Bryan Lau 13, Geetanjali Chander 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 84. | Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial |
| |
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1112-1127.doi: 10.1016/S2468-1253(22)00275-8.
Alain H Litwin 1, Paula J Lum 2, Lynn E Taylor 3, Shruti H Mehta 4, Judith I Tsui 5, Judith Feinberg 6, Arthur Y Kim 7, Brianna L Norton 8, Moonseong Heo 9, Julia Arnsten 8, Paul Meissner 10, Alison Karasz 11, M Diane Mckee 11, John W Ward 12, Nirah Johnson 13, Irene Pericot-Valverde 14, Linda Agyemang 8, Ellen S Stein 2, Aurielle Thomas 15, Courtney Borsuk 4, Kendra L Blalock 5, Samuel Wilkinson 16, Katherine Wagner 17, Jillian Roche 7, Cristina Murray-Krezan 18, Jessica Anderson 17, Vanessa Jacobsohn 19, Anne F Luetkemeyer 2, Oluwaseun Falade-Nwulia 20, Kimberly Page 17; HERO Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 94. | Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease |
| |
Kidney Int. 2022 Dec;102(6):1228-1237. doi: 10.1016/j.kint.2022.07.012.
Paul Martin 1, Ahmed A Awan 2, Marina C Berenguer 3, Annette Bruchfeld 4, Fabrizio Fabrizi 5, David S Goldberg 6, Jidong Jia 7, Nassim Kamar 8, Rosmawati Mohamed 9, Mário Guimarães Pessôa 10, Stanislas Pol 11, Meghan E Sise 12, Ethan M Balk 13, Craig E Gordon 14, Gaelen Adam 13, Michael Cheung 15, Amy Earley 15, Michel Jadoul 16
|
|
| |
|
|
| |
| 96. | Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus Erythematosus |
| |
New Microbiol. 2022 Dec;45(4):296-303.
Alessandra Lo Presti 1, Fulvia Ceccarelli 2, Maria Dorrucci 1, Francesca Farchi 1, Carmelo Pirone 2, Cristina Garufi 2, Catia Valdarchi 1, Francesca Romana Spinelli 2, Cristiano Alessandri 2, Paola Chionne 1, Elisabetta Madonna 1, Giulio Pisani 3, Antonio Martina 3, Matteo Simeoni 3, Roberto Bruni 1, Massimo Ciccozzi 4, Giancarlo Iaiani 5, Anna Rita Ciccaglione 1, Enea Spada 1, Fabrizio Conti 2
|
|
| |
| 97. | HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago |
| |
J Public Health (Oxf). 2022 Dec 1;44(4):891-899. doi: 10.1093/pubmed/fdab190.
Sandra Tilmon 1, A Aronsohn 2, B Boodram 3, L Canary 4, S Goel 5, T Hamlish 6, S Kemble 7, D S Lauderdale 8, J Layden 9, K Lee 1, A J Millman 4, N Nelson 4, K Ritger 10, I Rodriguez 1, N Shurupova 11, J Wolf 12, D Johnson 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 101. | Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019 |
| |
Am J Public Health. 2022 Dec 8;e1-e4. doi: 10.2105/AJPH.2022.307152. Online ahead of print.
Laura Hawks 1, Emily A Wang 1, Adeel A Butt 1, Stephen Crystal 1, D Keith McInnes 1, Vincent Lo Re 3rd 1, Emily J Cartwright 1, Lisa B Puglisi 1, Lamia Y K Haque 1, Joseph K Lim 1, Amy C Justice 1, Kathleen A McGinnis 1
|
|
| |
|
|
| |
| 103. | Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study |
| |
Clin Infect Dis. 2022 Nov 14;75(10):1809-1819. doi: 10.1093/cid/ciac246.
Joanne M Carson 1, Gregory J Dore 1, Andrew R Lloyd 1, Jason Grebely 1, Marianne Byrne 1, Evan Cunningham 1, Janaki Amin 2, Peter Vickerman 3, Natasha K Martin 4, Carla Treloar 5, Marianne Martinello 1, Gail V Matthews 1, Behzad Hajarizadeh 1; Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C) Study Group
|
|
| |
| 104. | Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use |
| |
Int J Drug Policy. 2022 Nov 13;111:103906. doi: 10.1016/j.drugpo.2022.103906.Online ahead of print.
Max Spaderna 1, Sarah Kattakuzhy 2, Sun Jung Kang 3, Nivya George 4, Phyllis Bijole 5, Emade Ebah 6, Rahwa Eyasu 6, Onyinyechi Ogbumbadiugha 6, Rachel Silk 6, Catherine Gannon 7, Ashley Davis 6, Amelia Cover 6, Britt Gayle 6, Shivakumar Narayanan 4, Maryland Pao 8, Shayamasundaran Kottilil 6, Elana Rosenthal 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 109. | Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy |
| |
Obstet Gynecol. 2022 Dec 1;140(6):997-999. doi: 10.1097/AOG.0000000000004980.Epub 2022 Nov 2.
Kate R Woodworth 1, Suzanne M Newton, Emily O Olsen, Ayzsa Tannis, Lindsey Sizemore, Heather Wingate, Lauren Orkis, Bethany Reynolds, Nicole Longcore, Nadia Thomas, Angelica Bocour, Aprielle Wills, Shin Y Kim, Lakshmi Panagiotakopoulos, Carolyn Wester, Dana Delman Meaney, Suzanne M Gilboa, Van T Tong
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 118. | Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort |
| |
Cancers (Basel). 2022 Oct 27;14(21):5280. doi: 10.3390/cancers14215280.
Ilona Argirion 1, Jalen Brown 1, Sarah Jackson 1, Ruth M Pfeiffer 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly J Yu 1, Katherine A McGlynn 1, Jessica L Petrick 3, Ligia A Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Hwai-I Yang 5 7 8 9, Mei-Hsuan Lee 7, Jill Koshiol 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 122. | Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection |
| |
J Am Heart Assoc. 2022 Oct 4;11(19):e026473.doi: 10.1161/JAHA.122.026473.Epub 2022 Sep 21.
Raynell Lang 1 2, Elizabeth Humes 2, Brenna Hogan 2, Jennifer Lee 2, Ralph D'Agostino 3, Joseph Massaro 4, Arthur Kim 5 6, James B Meigs 6 7, Leila Borowsky 7, Wei He 7, Asya Lyass 3, David Cheng 8, H Nina Kim 9, Marina B Klein 10, Edward R Cachay 11, Ronald J Bosch 12, M John Gill 1, Michael J Silverberg 13, Jennifer E Thorne 14, Kathleen McGinnis 15, Michael A Horberg 16, Timothy R Sterling 17, Virginia A Triant 5 7, Keri N Althoff 2
|
|
| |
|
|
| |
|
|
| |
| 125. | Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study |
| |
Int J Drug Policy. 2022 Oct 11;110:103876. doi: 10.1016/j.drugpo.2022.103876.Online ahead of print.
Heather Valerio 1, Anna Conway 2, Maryam Alavi 3, Carla Treloar 4, David Silk 3, Carolyn Murray 5, Charles Henderson 6, Janaki Amin 7, Phillip Read 8, Louisa Degenhardt 9, Michael Christmass 10, Mark Montebello 11, Gregory J Dore 3, Jason Grebely 3, ETHOS Engage Study Group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 133. | Hepatitis C Virus-Specific Immune Responses Following Direct Acting Antivirals Administered During Recent Hepatitis C Virus Infection |
| |
J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13761. Online ahead of print.
Julia L Casey 1 2, Gregory J Dore 3, Jason Grebely 3, Gail V Matthews 3, Vera Cherepanov 1, Marianne Martinello 3, Philippa Marks 3, Harry L A Janssen 1, Bettina E Hansen 1 4, Rupert Kaul 5 6, Sonya A MacParland 7 8, Adam J Gehring 1 5, Jordan J Feld 1 2
|
|
| |
| 134. | Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort |
| |
Front Oncol. 2022 Oct 13;12:983238. doi: 10.3389/fonc.2022.983238. eCollection 2022.
Maryam Darvishian 1 2, Terry Tang 1, Stanley Wong 3, Mawuena Binka 3 4, Amanda Yu 3, Maria Alvarez 3, Héctor Alexander Velásquez García 3, Prince Asumadu Adu 3 4, Dahn Jeong 3 4, Sofia Bartlett 3, Mohammad Karamouzian 3 5 6, Jean Damascene Makuza 3 4, Jason Wong 3, Alnoor Ramji 4, Ryan Woods 1 7, Mel Krajden 3 4, Naveed Janjua 3 4, Parveen Bhatti 1 2
|
|
| |
|
|
| |
|
|
| |
| 137. | Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020) |
| |
Int J Drug Policy. 2022 Nov;109:103872. doi: 10.1016/j.drugpo.2022.103872.Epub 2022 Oct 3.
Norah Palmateer 1, Victoria Hamill 2, Anne Bergenstrom 3, Harriet Bloomfield 4, Lara Gordon 5, Jack Stone 5, Hannah Fraser 5, Thomas Seyler 3, Yuejiao Duan 4, Richard Tran 4, Kirsten Trayner 2, Christopher Biggam 2, Shanley Smith 2, Peter Vickerman 5, Matt Hickman 5, Sharon Hutchinson 2
|
|
| |
|
|
| |
|
|
| |
| 140. | Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost? |
| |
Can J Gastroenterol Hepatol. 2022 Oct 14;2022:3449938. doi: 10.1155/2022/3449938.eCollection 2022.
David Stephen Prince 1 2 3, Julia Di Girolamo 1 2, Joseph Louis Pipicella 1 2, Melissa Bagatella 1, Tahrima Kayes 1 2, Frank Alvaro 1 4, Michael Maley 1 3 4, Hong Foo 1 4 5, Paul MacConachie Middleton 1 2 3 6 7, Miriam Tania Levy 1 2 3
|
|
| |
| 141. | Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs |
| |
J Subst Abuse Treat. 2022 Sep;140:108768. doi: 10.1016/j.jsat.2022.108768. Epub 2022 Mar 18.
Alison Karasz 1, Reena Singh 2, M Diane McKee 3, Krupa Merchant 4, Arthur Y Kim 5, Kimberly Page 6, Irene Pericot-Valverde 7, Ellen S Stein 8, Lynn E Taylor 9, Katherine Wagner 10, Alain H Litwin 11
|
|
| |
| 142. | Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs |
| |
J Viral Hepat. 2022 Oct;29(10):908-918. doi: 10.1111/jvh.13723. Epub 2022 Jul 5.
Michael W Traeger 1 2, Daniela K van Santen 1 2 3, Rachel Sacks-Davis 1 2, Jason Asselin 1, Allison Carter 4 5 6, Joseph S Doyle 1 7, Alisa Pedrana 1 2, Anna L Wilkinson 1 2, Jessica Howell 1 8 9, Rebecca Thatcher 10, John Didlick 11, Basil Donovan 4 12, Rebecca Guy 4, Margaret E Hellard 1 7 13, Mark A Stoové 1 2, Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS)
|
|
| |
|
|
| |
| 144. | Non-targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region |
| |
J Am Coll Emerg Physicians Open. 2022 Sep 12;3(5):e12819. doi: 10.1002/emp2.12819.eCollection 2022 Oct.
Cody A Chastain 1, Cathy A Jenkins 2, Michelle Rose 3, Daniel Moore 4, Diana Parker 5, Barbra Cave 6, Jane Crowe 7, Sarah Adams 7, Marrieth G Rubio 8, Rachel Potter 9, Kimberly Quedado 10, Ian D Jones 11, Jin H Han 12, Wesley H Self 13
|
|
| |
|
|
| |
| 146. | The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population |
| |
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac445. doi: 10.1093/ofid/ofac445.eCollection 2022 Sep.
Nicole D Ferrante 1 2, Craig W Newcomb 2, Kimberly A Forde 3, Charles E Leonard 2 4, Jessie Torgersen 2 5, Benjamin P Linas 6, Sarah E Rowan 7, David L Wyles 7, Jay Kostman 8, Stacey B Trooskin 5 8, Vincent Lo Re 3rd 2 5
|
|
| |
|
|
| |
|
|
| |
| 149. | HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic |
| |
J Viral Hepat. 2022 Sep 5. doi: 10.1111/jvh.13746. Online ahead of print.
Lukas Hartl 1 2, Mathias Jachs 1 2, David Bauer 1 2, Benedikt Simbrunner 1 2, David Chromy 1 2 3, Teresa Binter 1 2, Lisa Steininger 1 2, Caroline Schwarz 2 4, Michael Schwarz 2 4, Lukas Burghart 2 4, Robert Strassl 5, Michael Trauner 1, Michael Gschwantler 4, Mattias Mandorfer 1 2, Thomas Reiberger 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 165. | Randomized clinical trial: Direct-acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection |
| |
J Viral Hepat. 2022 Aug;29(8):646-653. doi: 10.1111/jvh.13701.Epub 2022 May 26.
Lewis Beer 1, Sarah Inglis 1, Amy Malaguti 2, Christopher Byrne 1 3, Christian Sharkey 4, Emma Robinson 3 4, Kirsty Gillings 5, Andrew Radley 6, Adrian Hapca 1, Brian Stephens 4, John Dillon 3 4
|
|
| |
|
|
| |
|
|
| |
| 168. | Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study |
| |
Ann Intern Med. 2022 Sep;175(9):1221-1229. doi: 10.7326/M21-4119. Epub 2022 Aug 9.
Jason Grebely 1, Gregory J Dore 1, Frederick L Altice 2, Brian Conway 3, Alain H Litwin 4, Brianna L Norton 4, Olav Dalgard 5, Edward J Gane 6, Oren Shibolet 7, Ronald Nahass 8, Anne F Luetkemeyer 9, Cheng-Yuan Peng 10, David Iser 11, Isaias Noel Gendrano 12, Michelle M Kelly 12, Peggy Hwang 12, Ernest Asante-Appiah 12, Barbara A Haber 12, Eliav Barr 12, Michael N Robertson 12, Heather Platt 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 172. | Hepatitis C virus infection preceding an outbreak of HIV among persons who inject drugs- Kanawha County, West Virginia, 2019-2021 |
| |
Clin Infect Dis. 2022 Jul 29;ciac619. doi: 10.1093/cid/ciac619. Online ahead of print.
Alana G Hudson 1, Robert A Bonacci 2 3, Anne C Moorman 4, McKenna Penley 5 6, Suzanne M Wilson 1, Jessica L Hoffman 1, Erica R Thomasson 7 8, R Paul McClung 3, Danae Bixler 4
|
|
| |
|
|
| |
| 174. | Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study |
| |
Open Forum Infect Dis. 2022 Jul 28;9(8):ofac350. doi: 10.1093/ofid/ofac350.eCollection 2022 Aug.
Timothy Papaluca 1, Anne Craigie 1, Lucy McDonald 1, Amy Edwards 1, Rebecca Winter 1, Annabelle Hoang 1, Alex Pappas 1, Aoife Waldron 1, Kelsey McCoy 1, Mark Stoove 2, Joseph Doyle 2, Margaret Hellard 2, Jacinta Holmes 1, Michael MacIsaac 1, Paul Desmond 1, David Iser 1, Alexander J Thompson 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 180. | A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study |
| |
Viruses. 2022 Jul 16;14(7):1555. doi: 10.3390/v14071555.
Anna Conway 1 2, Heather Valerio 1, Maryam Alavi 1, David Silk 1, Carla Treloar 2, Behzad Hajarizadeh 1, Alison D Marshall 1 2, Marianne Martinello 1, Andrew Milat 3, Adrian Dunlop 4 5, Carolyn Murray 6, Bianca Prain 6, Charles Henderson 7, Janaki Amin 8, Phillip Read 9, Pip Marks 1, Louisa Degenhardt 10, Jeremy Hayllar 11, David Reid 12, Carla Gorton 13, Thao Lam 14, Michael Christmass 15 16, Alexandra Wade 17 18, Mark Montebello 19, Gregory J Dore 1, Jason Grebely 1, ETHOS Engage Study Group
|
|
| |
| 181. | LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients |
| |
Biomark Med. 2022 Aug;16(11):839-846. doi: 10.2217/bmm-2021-0596. Epub 2022 Jul 5.
Akif Altinbas 1, Jacinta A Holmes 1, Shadi Salloum 1, Anna Lidofsky 1, Nadia Alatrakchi 1, Ma Somsouk 2, Peter Hunt 2, Steven Deeks 2, Kara W Chew 3, Georg Lauer 1, Annie Kruger 1, Wenyu Lin 1, Raymond T Chung 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 185. | VirA+EmiC project: Evaluating real-world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department |
| |
J Viral Hepat. 2022 Jul;29(7):559-568. doi: 10.1111/jvh.13676. Epub 2022 Apr 9.
Gaia Nebbia 1, Murad Ruf 2, Laura Hunter 3, Sooria Balasegaram 4, Terry Wong 5, Ranjababu Kulasegaram 6, Julian Surey 7 8, Zana Khan 9, Jack Williams 10, Basel Karo 11, Luke Snell 1, Barnaby Flower 12, Hannah Evans 4 13, Sam Douthwaite 1
|
|
| |
|
|
| |
| 187. | Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis |
| |
J Addict Med. 2022 Jul-Aug;16(4):e248-e256. doi: 10.1097/ADM.0000000000000937.Epub 2021 Nov 18.
Brittany B Dennis 1, Leslie J Martin, Leen Naji, Daud Akhtar, George Cholankeril, Donghee Kim, Nitika Sanger, Alannah Hillmer, Caroul Chawar, Alessia D'Elia, Balpreet Panesar, Andrew Worster, David C Marsh, Tim O'Shea, Monica Bawor, Lehana Thabane, Zainab Samaan, Aijaz Ahmed
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 194. | Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada |
| |
Liver Int. 2022 Jul;42(7):1528-1535. doi: 10.1111/liv.15237. Epub 2022 Mar 28.
Kyle A Thompson 1, Gabriel Blank 2, Junine Toy 1, David M Moore 1 2, Nathan Lachowsky 3, Nicanor Bacani 1, Wendy Zhang 1, Paul Sereda 1, Viviane D Lima 1 2, Rolando Barrios 1, Julio S G Montaner 1 2, Mark W Hull 1 2
|
|
| |
| 195. | Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R) |
| |
Viruses. 2022 Jul 14;14(7):1541. doi: 10.3390/v14071541.
Markus Cornberg 1, Albrecht Stoehr 2, Uwe Naumann 3, Gerlinde Teuber 4, Hartwig Klinker 5, Thomas Lutz 6, Hjördis Möller 7, Dennis Hidde 8, Kristina Lohmann 8, Karl-Georg Simon 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 199. | Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018 |
| |
Prev Med. 2022 Aug;161:107136. doi: 10.1016/j.ypmed.2022.107136. Epub 2022 Jul 5.
Brittney L Dickey 1, Anna E Coghill 1, Julie A Rathwell 1, Richard R Reich 2, Susan T Vadaparampil 3, Shannon M Christy 4, Richard Roetzheim 5, Elizabeth Shenkman 6, Anna R Giuliano 7
|
|
| |
|
|
| |
| 201. | Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication |
| |
J Hepatol. 2022 Jul;77(1):55-62. doi: 10.1016/j.jhep.2022.01.027. Epub 2022 Feb 12.
Peter P Mueller 1, Qiushi Chen 2, Turgay Ayer 3, Gizem S Nemutlu 1, Ali Hajjar 1, Emily D Bethea 4, Mary Linton B Peters 5, Brian P Lee 6, Naveed Z Janjua 7, Fasiha Kanwal 8, Jagpreet Chhatwal 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 209. | Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV |
| |
HIV Med. 2022 Jul;23(6):620-628. doi: 10.1111/hiv.13218. Epub 2021 Dec 23.
Sarah J Willis 1, H Nina Kim 2, Chad J Achenbach 3, Edward R Cachay 4, Katerina A Christopoulos 5, Heidi M Crane 2, Ricardo A Franco 6, Christopher B Hurt 7, Mari M Kitahata 2, Richard D Moore 8, Michael J Silverberg 9, Phyllis C Tien 5 10, Daniel Westreich 11, Julia L Marcus 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 217. | Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression |
| |
Lancet HIV. 2022 Jun;9(6):e414-e427.doi: 10.1016/S2352-3018(22)00077-7.
Samira Hosseini-Hooshyar 1, Behzad Hajarizadeh 2, Sahar Bajis 2, Matthew Law 2, Naveed Z Janjua 3, Daniel S Fierer 4, David Chromy 5, Jürgen K Rockstroh 6, Thomas C S Martin 7, Patrick Ingiliz 8, Chien-Ching Hung 9, Gregory J Dore 2, Marianne Martinello 2, Gail V Matthews 2
|
|
| |
|
| | | | | |
